NEW OPPORTUNITIES IN TREATMENT OF IRRITABLE BOWEL SYNDROME: EFFECTIVE APPROACH AND CORRECTION OF THE QUALITY OF LIFE


I.V. Maev, A.A. Samsonov, A.V. Yashina, A.N. Kazyulin, V.A. Shestakov

SBEI HPE “Moscow State Medical Stomatological University n.a. A.I. Evdokimov” of RMH, Moscow
The article presents the results of the comparative non-interventional clinical study in parallel groups aimed to the evaluation of the efficacy and safety of use Kolofort® in therapy of irritable bowel syndrome (IBS) compared to trimebutine. The findings obtained allow to recommend Kolofort® for widespread use in the treatment of IBS that will has a positive impact on the quality of life of patients.

About the Autors


A.V. Yashina – Postgraduate student at the Department of Propedeutics of Internal Diseases and Gastroenterology SBEI HPE MSMSU n.a. A.I. Evdokimov of RMH, Moscow


Similar Articles


Бионика Медиа